Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 49
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

Biological control of the mosquito Aedes aegypti

The mosquito A. aegypti is the main vector for dengue and zika viruses. This mosquito has developed resistance...

Increasing survival of macaw chicks using foster macaw parents in the wild

Wild Scarlet Macaw populations are declining due to the illegal trade and habitat loss. Although Scarlet...

Backer Badge Funded